IMGT (XKRX:456570) Other Current Liabilities : ₩23,961.77 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is IMGT Other Current Liabilities?

IMGT's other current liabilities for the quarter that ended in Dec. 2023 was ₩23,961.77 Mil.

IMGT's quarterly other current liabilities declined from Dec. 2021 (₩47,625.29 Mil) to Dec. 2022 (₩40,384.67 Mil) and declined from Dec. 2022 (₩40,384.67 Mil) to Dec. 2023 (₩23,961.77 Mil).

IMGT's annual other current liabilities declined from Dec. 2021 (₩47,625.29 Mil) to Dec. 2022 (₩40,384.67 Mil) and declined from Dec. 2022 (₩40,384.67 Mil) to Dec. 2023 (₩23,961.77 Mil).

IMGT Other Current Liabilities Historical Data

The historical data trend for IMGT's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Other Current Liabilities Chart

IMGT Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

IMGT Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Other Current Liabilities	-	-	-	-

IMGT Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

IMGT Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of IMGT's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605

Website

http://www.imgt.co.kr

IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines